• All
• A
• B
• C
• D
• E
• F
• G
• H
• I
• J
• K
• L
• M
• N
• O
• P
• Q
• R
• S
• T
• U
• V
• W
• X
• Y
• Z

• K
• Kamble, Nitin
  University of Cincinnati
• (M1030-01-07) E. coli Nissle 1917-Based Bacterial Cell Therapy Helps Restore Intestinal Barrier and Improve Post-Myocardial Infarction Outcomes
  Nitin Kamble
  Favorite
• Kasinath, Aparna
  Syngene International Ltd.
• (M1430-01-08) Antibody Titration: Titer Cut-Point or Screening Cut-Point: Which One Is a Practical Option?
  Aparna Kasinath
  Favorite
• (T1430-01-09) An Orthogonal Bioanalytical Approach to Assess the Immunogenicity and Efficacy of Covid-19 Vaccines
  Aparna Kasinath
  Favorite
• Katz, Joshua
  IFF
• (M1330-01-03) FM1000 Surfactant is Compatible with Downstream Bioprocessing
  Joshua Katz
  Favorite
• (T1430-01-01) Alginate Hydrogels: A Tunable Tool for Biotech Applications
  Joshua Katz
  Favorite
• Keasey, Nikki
  Alliance Pharma Inc.
• (T1430-01-04) A Sensitive Electrochemiluminescence-Based Method for the Detection of Anti-drug Antibodies against Anti-PD-1 Antibody Drug Pembrolizumab in Human Serum
  Nikki Keasey
  Favorite
• Kelly, Sam
  Century Therapeutics, Inc.
• (T1130-01-02) Evaluating a Merged Well Analysis Strategy for Validation of a Cellular Kinetics Assay to Quantify an Allogeneic Cell Product in Human Blood by ddPCR
  Sam Kelly
  Favorite
• Keyhani, Anahita
  Altasciences
• (M1330-01-05) Application of Mitra Microsampling for the Quantitative Bioanalysis of Antisense Oligonucleotides
  Anahita Keyhani
  Favorite
• Khraisat, Rama
  Yonsei University
• (T1330-01-07) Preparation and Evaluation of Protein Encapsulated Liposome Using Surfactant for Dry Powder Inhalation
  Rama Khraisat
  Favorite
• Kiesler, Kevin
  National Institute of Standards and Technology
• (M1130-01-06) Structural Profiling of mRNA Vaccine Constructs: Applications for mRNA Vaccine Design and Quality Assessment
  Kevin Kiesler
  Favorite
• Kim, Bumjun
  Princeton University
• (T1130-01-06) Development and Optimization of Next-Generation Lipid Nanoparticles for In Situ CAR-T Production
  Bumjun Kim
  Favorite
• Kim, Daniel
  PPD, a part of Thermo Fisher Scientific
• (M1030-01-05) Use of Technical Replicate Precision Acceptance for qPCR- and ddPCR-based Validations and Sample Testing
  Daniel Kim
  Favorite
• Kim, Haneul
  Yonsei University
• (T1330-01-04) Characterization and In Vivo Evaluation of Oil Based Anti-adhesion Agent with Xanthan Gum
  Haneul Kim
  Favorite
• Kim, Johan
  NGM Biopharmaceuticals
• (M1430-01-03) Achieving Drug Tolerance in a Multiplexed Neutralizing Antibody Assay (nAb) Using Competition and Heat Solid Phase Extraction (SPE) Conditions
  Johan Kim
  Favorite
• Kizekai, Lavelay
  Waters Corporation
• (T1030-01-02) Modification of Particle and Hardware Surfaces for Efficient Biotherapeutic Method Development
  Lavelay Kizekai
  Favorite
• Klauss, Linda
  Gyros Protein Technologies
• (M1030-01-01) Measuring Free IgE in Low-Affinity Interaction with Omalizumab Using an Automated Microfluidic Immunoassay to Support Pharmacokinetics and Pharmacodynamics Studies
  Linda Klauss
  Favorite
• Klieber, Sylvie
  Sanofi
• (M1330-01-06) In Vitro Assessment of Physicochemical Properties of Biologics for the Early Identification of Pharmacokinetic Liabilities in a Developability Workflow
  Sylvie Klieber
  Favorite
• Koch, Sheryl
  University of Cincinnati College of Medicine
• (M1030-01-07) E. coli Nissle 1917-Based Bacterial Cell Therapy Helps Restore Intestinal Barrier and Improve Post-Myocardial Infarction Outcomes
  Sheryl Koch
  Favorite
• Kotagiri, Nalinikanth
  University of Cincinnati College of Pharmacy
• (M1030-01-07) E. coli Nissle 1917-Based Bacterial Cell Therapy Helps Restore Intestinal Barrier and Improve Post-Myocardial Infarction Outcomes
  Nalinikanth Kotagiri
  Favorite
• Kozhich, Alexander
  Bristol-Myers Squibb Company
• (T1030-01-04) Short-Term Tacrolimus/Sirolimus Combination Therapy Induces Long-Term Immune Tolerance to a Human Monoclonal Antibody in Rats
  Alexander Kozhich
  Favorite
• (T1330-01-02) Screening and Epitope Binning of Anti-idiotypic Antibodies against Therapeutic Bispecific Antibodies Using the Gyros Immunoassay Platform
  Alexander Kozhich
  Favorite
• Krick, Alain
  Sanofi
• (M1330-01-06) In Vitro Assessment of Physicochemical Properties of Biologics for the Early Identification of Pharmacokinetic Liabilities in a Developability Workflow
  Alain Krick
  Favorite
• Kumar, Mahesh
  Syngene International Ltd.
• (M1430-01-08) Antibody Titration: Titer Cut-Point or Screening Cut-Point: Which One Is a Practical Option?
  Mahesh Kumar
  Favorite
• (T1430-01-09) An Orthogonal Bioanalytical Approach to Assess the Immunogenicity and Efficacy of Covid-19 Vaccines
  Mahesh Kumar
  Favorite
• Kwok, Rosanna
  Genentech, Inc.
• (M1030-01-06) Investigating the Impact of a Soluble Target on ADA Measurements in a Bispecific Antibody Clinical Study
  Rosanna Kwok
  Favorite